UK and India seeking cooperation on science and technology

29 July 2010

The UK and India are planning wide-ranging agreements in science and technology to cement bilateral cooperation in medicine, R&D, ICT, energy and education to the benefit of both countries.

The plans were unveiled in the southern Indian cities of Bangalore and Chennai yesterday. UK Prime Minister David Cameron is leading a major delegation to India of UK government ministers, including Business Secretary Vince Cable and Universities and Science Minister David Willetts. The delegation also includes businesspeople, academics and cultural figures.

In a keynote speech in Bangalore at Infosys, India's largest IT company, the UK's Prime Minister discussed cooperation on science and technology. He said, among other things, that UK and India research funders have committed up to £60 million ($92.4 million) worth of jointly-funded research into climate change, water and food security and disease prevention. Included in this, the Wellcome Trust has announced £45 million of research with the Indian Department of Biotechnology on affordable health care.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical